Rinvoq ER 30 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F9HQE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,679
Award facts
- Contract value 100% obligated
- $10,679.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on March 27, 2026, for RINVOQ ER 30 mg tablets (30-count units) with a ceiling value of $10,679.42.
Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of March 30, 2026. No set-aside was used.
Quick answers
Who was awarded contract SPE2DR26F9HQE?
SPE2DR26F9HQE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on March 27, 2026.
How much is contract SPE2DR26F9HQE worth?
The government has obligated $10,679 on SPE2DR26F9HQE.
Is contract SPE2DR26F9HQE an order under another contract?
Yes. SPE2DR26F9HQE is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9HQE competed?
The extent of competition for SPE2DR26F9HQE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award